肿瘤疫苗在肺癌治疗中的研究进展

Research progress of tumor vaccines in the treatment of lung cancer

肺癌是全球癌症相关死亡的首要原因。目前,肺癌主要通过放化疗、手术进行治疗,约40%的患者易复发,晚期生存率不足15%,治疗效果欠佳。随着现代医学的发展,免疫治疗的出现引起了医学界的广泛关注和重视。近年来,国内外医学研究者纷纷投入到肿瘤疫苗的研究中,利用抗原诱导机体产生特异性免疫反应治疗肺癌,取得良好的临床疗效。本文围绕肿瘤疫苗治疗肺癌的研究进展进行综述.

Lung cancer is the leading cause of cancer-related death globally.Currently,lung cancer is mainly treated by radiotherapy,chemotherapy and surgery.Approximately 40%of patients are prone to relapse,and the survival rate in the advanced stages is less than 15%,indicating poor treatment outcomes.With the development of modern medicine,the emergence of immunotherapy has garnered widespread attention and importance in the medical community.In recent years,medical researchers at home and abroad have been actively engaged in the research of tumor vaccines,utilizing antigens to induce specific immune responses against lung cancer,achieving good clinical outcomes.This article provides a comprehensive review of the research progress in the treatment of lung cancer with tumor vaccines.